News

Biotech's Boom Suffers a Setback in March April 01, 2014 | Press Release

Investors Flock to Biotech March 03, 2014 | Press Release

Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release

  See all News
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.


2011 News Archive


                 

Debt Worries, Political Dysfunction Take a Toll on Biotech in Third Quarter

Biotech stocks fall with the market as financing activity slows

October 03, 2011

› Learn more

 

Promise of Personalized Medicine Remains Unrealized

Burrill & Company Meeting Explores the Challenges Faced by the Drugs, Tools, and Diagnostics Companies Leading a Revolution in Healthcare

September 15, 2011

› Learn more

 

Volatile Markets in August Take a Toll on Life Sciences IPOs

Burrill & Company says poor performance for new issues, depressed stocks, could fuel surge in M&A

August 31, 2011

› Learn more

 

New Drug Approvals in 2011 Already Match 2010 Total

Burrill & Company sees environment improving for life sciences, but macroeconomic threats persist.

July 31, 2011

› Learn more

                         

M&A Has Failed to Build Value for Pharma, Burrill Annual Biotech Report Finds

Pressure to Find Better Models to Discover and Develop New Drugs Increases

April 12, 2011

› Learn more

       

Boom Times for Genomics Startups

Investment is picking up as sales of gene sequencing machines surge

March 17, 2011

› Learn more

 

Dirk Lammerts joins Burrill Venture Capital Group

Focus will be on building the company’s activities in digital health

March 10, 2011

› Learn more

          
News Archive: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | View All